NYSE · DNA
Ginkgo Bioworks Holdings, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for DNA: Nov 5, 2026
Ginkgo Bioworks Holdings, Inc. Class A Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.58. The reported EPS for the same quarter last year was $-1.45.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.58 | $-0.58 | $-0.58 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · Fintel · BNK Invest- Zacks · Oct 29, 5:15 PM EDTGinkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key InsightsGinkgo Bioworks Holdings, Inc. (DNA) closed at $12.74 in the latest trading session, marking a -4.35% move from the prior day.
- The Motley Fool · Oct 29, 4:42 AM EDTCathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.Ark Invest has been buying Archer Stock during pullbacks.
- Fintel · Oct 23, 5:58 AM EDTGinkgo Bioworks Holdings Consensus Price Target Raised 14.29% to $8.16The average one-year price target for Ginkgo Bioworks Holdings (NYSE:DNA) (BMV:DNA) has been revised to $8.16 / share, as of October 20, 2026. This is an increase of 14.29% from the prior estimate of $7.14 dated September 29, 2026. These figures represent aggregate analyst target
- Zacks · Oct 20, 5:15 PM EDTGinkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to KnowGinkgo Bioworks Holdings, Inc. (DNA) reached $9.86 at the closing of the latest trading day, reflecting a -2.09% change compared to its last close.
- Zacks · Oct 14, 5:15 PM EDTHere's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader MarketIn the most recent trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $11.53, indicating a -1.96% shift from the previous trading day.
- Zacks · Oct 7, 5:15 PM EDTGinkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to KnowGinkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $11.47, moving 7.57% from the previous trading session.
- BNK Invest · Oct 5, 3:27 PM EDTNotable Monday Option Activity: NFLX, DNA, PRMBAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Netflix Inc (Symbol: NFLX), where a total of 280,679 contracts have traded so far, representing approximately 28.1 million underlying shares. That amounts to about 78.4%
- The Motley Fool · Oct 5, 12:05 PM EDTThis Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares DoubledGinkgo Bioworks and Eli Lilly announced a partnership last month focused on AI drug discovery.
- Zacks · Sep 23, 5:15 PM EDTGinkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to KnowIn the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $8.58, marking a -8.43% move from the previous day.
- Zacks · Sep 18, 12:31 PM EDTGinkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?Ginkgo Bioworks (DNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- RTTNews · Sep 18, 10:44 AM EDTWeekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead(RTTNews) – Biotech investors tracked a busy week marked by regulatory approvals, strategic collaborations, workforce restructuring and key clinical trial readouts.
- Zacks · Sep 16, 6:15 PM EDTGinkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key FactsGinkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $7.06, signifying a +1% move from its prior day's close.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Ginkgo Bioworks Holdings, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.